Dewpoint therapeutics inc
WebVice President and Corporate Controller at Dewpoint Therapeutics, Inc. Boston, Massachusetts, United States. 328 followers 323 connections. Join to view profile Dewpoint Therapeutics ... WebOct 13, 2024 · Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that ...
Dewpoint therapeutics inc
Did you know?
WebDew Point One LLC. SIC Code 73,737. NAICS Code 54,541. Show More. Top Competitors of Dewpoint. Ventera Corp. 250. $71.1M. 1 . Advanced Systems Group LLC ... Volastra Therapeutics and Dewpoint Therapeutics today announced a research and development partnership to discover novel modulators of biomolecular condensates to prevent cancer … WebFeb 3, 2024 · BOSTON, Feb. 3, 2024 /PRNewswire/ -- Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing.
WebSep 29, 2024 · Dewpoint Therapeutics announced Tuesday that it has raised $77 million in its second round of venture funding, which will help the company continue to target “undruggable” diseases through an ... WebPalantir and Dewpoint Therapeutics Announce Strategic Partnership DENVER & BOSTON--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of operating systems for the modern enterprise, and Dewpoint Therapeutics (“Dewpoint"), the leading biomolecular condensates company, today announced a partnership for …
WebMay 25, 2024 · BOSTON, May 25, 2024 — Dewpoint Therapeutics Inc., today announced the US Patent and Trademark Office (USPTO) issued the patent “Methods of Screening for Condensate-Associated Specificity and Uses Thereof” (U.S. Patent No. 11,340,231) covering novel technology for screening compounds capable of modulating biomolecular … WebMar 23, 2024 · Dewpoint Therapeutics' scientific founder brokered a meeting between his company and Novo Nordisk, resulting in a $745 million deal for the Boston biotech. The Business Journals .
WebJul 21, 2024 · BOSTON, July 21, 2024 /PRNewswire/ -- Dewpoint Therapeutics, Inc. today announced biomolecular scientist Anthony Hyman, head of the Max Planck Institute of Molecular Cell Biology and Genetics (MPI ...
WebPalantir and Dewpoint Therapeutics Announce Strategic Partnership DENVER & BOSTON--(BUSINESS WIRE)--Palantir Technologies Inc. (NYSE: PLTR), a leading builder of … ready armsWebDewpoint Therapeutics Jan 2024 - Present 4 months. Boston, Massachusetts, United States Senior Scientist Boston Children's … how to take a long screenshot on windowsready artworkWebDec 9, 2024 · Dewpoint Therapeutics is the first company to apply the emerging understanding of biomolecular condensates to drug discovery. Dewpoint believes that a vast range of conditions have pathways that ... how to take a magnetic tag offWebFeb 3, 2024 · BOSTON , Feb. 3, 2024 /PRNewswire/ -- Dewpoint Therapeutics, Inc., the biomolecular condensates company, today announced the completion of a $150 million Series C financing. The funding round was led by SoftBank Vision Fund 2, along with other new investors General Catalyst, Mubadala Capital, 3E Bioventures, Mirae Asset Capital, … how to take a mirror selfieWebMar 22, 2024 · Dewpoint Therapeutics today announced a research and development partnership with Novo Nordisk to identify drug candidates using Dewpoint's discovery platform related to biomolecular condensates ... ready artsWeb11 rows · Dewpoint Therapeutics has raised a total of $287M in funding over 3 rounds. Their latest funding was raised on Feb 3, 2024 from a Series C round. Dewpoint Therapeutics is funded by 16 investors. SoftBank … how to take a macbook air screenshot